The U.S. House of Representatives has approved bipartisan legislation to reauthorize the Breast Cancer Education and Awareness Requires Learning Young (EARLY) Act, extending a federal initiative that has spent more than a decade helping young women recognize breast cancer risks, understand warning signs, and seek care earlier. The measure, passed on July 21, now moves to the U.S. Senate for consideration.

Originally enacted in 2010, the EARLY Act directs the Centers for Disease Control and Prevention (CDC) to lead education and awareness efforts aimed at women between the ages of 18 and 44, particularly those with elevated risk because of family history, inherited genetic mutations, or other factors. The new legislation would extend those programs through 2031 while preserving education campaigns, support services for young breast cancer survivors, and continuing medical education that helps healthcare providers identify breast cancer in younger patients.

Congressman Brian Fitzpatrick (R-Pa.), co-chair of the House Cancer Caucus, described the legislation as a victory for prevention and early detection. “America has made extraordinary progress in preventing, detecting, and treating cancer, but that progress only matters if it reaches the people whose lives depend on it,” Fitzpatrick said after House passage.

The House package also incorporates provisions from the bipartisan SCREENS for Cancer Act, which would strengthen the National Breast and Cervical Cancer Early Detection Program. Established in 1991, that CDC program has provided more than 16.5 million breast and cervical cancer screening examinations to over 6.4 million people, leading to the diagnosis of nearly 80,000 invasive breast cancers and thousands of invasive cervical cancers. The legislation seeks to improve patient navigation, reduce barriers to screening for uninsured and underinsured individuals, and expand access for medically underserved communities.

Why Earlier Detection Matters for Younger Women and Communities of Color

Although breast cancer is more commonly diagnosed after age 50, younger women can and do develop the disease. According to the CDC, breast cancer in younger women is often diagnosed at a later stage because routine mammography screening is generally not recommended for average-risk women under 40, making awareness of symptoms and individual risk especially important. The agency’s Bring Your Brave campaign, one of the EARLY Act’s signature initiatives, encourages women to learn their family history, recognize changes in their breasts, and talk with healthcare providers about their personal risk.

The need for earlier awareness is particularly significant for Black women. The American Cancer Society reports that while Black women are slightly less likely than White women to develop breast cancer overall, they are about 40% more likely to die from the disease. Researchers attribute these disparities to a combination of factors, including unequal access to high-quality care, delays in diagnosis, differences in tumor biology, and longstanding structural inequities in healthcare. Early diagnosis and timely treatment remain among the most effective ways to improve survival.

Young women diagnosed with breast cancer also face unique challenges that differ from those of older patients. Treatment decisions often involve fertility preservation, family planning, employment concerns, and the emotional impact of receiving a cancer diagnosis during early adulthood. The EARLY Act’s Young Breast Cancer Survivors Program supports organizations that provide education, survivorship resources, and practical assistance for these patients.

For individuals living with metastatic breast cancer (MBC), awareness campaigns also play an important role. While metastatic disease cannot currently be cured, advances in treatment have helped many patients live longer with a better quality of life. Earlier recognition of breast cancer symptoms and faster diagnosis may reduce the likelihood that some cancers progress before treatment begins, although not every metastatic diagnosis is preventable.

Patient advocates continue to emphasize that education should extend beyond screening recommendations to include conversations about breast health, family history, inherited cancer risk, and access to specialists. Many also stress the importance of culturally responsive care that recognizes the experiences of historically underserved communities.

The legislation has received support from more than 20 national cancer organizations, including the American Cancer Society Cancer Action Network, Susan G. Komen, Living Beyond Breast Cancer, Sharsheret, the Prevent Cancer Foundation, and other advocacy groups that have long promoted equitable access to cancer education and screening.

As lawmakers await Senate action, advocates say public awareness remains just as important as policy. Women diagnosed with metastatic breast cancer, caregivers, and supporters looking for education and community resources can learn more through the National Minority Quality Forum’s Support Our Sisters initiative at Support Our Sisters: Thriving With MBC & Chronic Disease. Those seeking peer support and shared experiences can also join the Support Our Sisters Facebook community at Support Our Sisters Facebook Group. As Congress considers the next step for the EARLY Act, health experts continue to emphasize that awareness, equitable access to care, and early action remain among the strongest tools for reducing the burden of breast cancer across all communities.